Recombinant multi-species KRT82 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine KRT82 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a member of the keratin gene family. As a type II hair keratin, it is a basic protein which heterodimerizes with type I keratins to form hair and nails. The type II hair keratins are clustered in a region of chromosome 12q13 and are grouped into two distinct subfamilies based on structure similarity. One subfamily, consisting of KRTHB1, KRTHB3, and KRTHB6, is highly related. The other less-related subfamily includes KRTHB2, KRTHB4, and KRTHB5. All hair keratins are expressed in the hair follicle; this keratin appears to be a hair cuticle-specific keratin. [provided by RefSeq, Jul 2008]
The Alternative Names of target: HB2,Hb-2,KRT82,KRTHB2,Kb22,Keratin,Keratin-82 (K82),Krt2-20,Krt82,Type II hair keratin Hb2,Type-II keratin Kb22,type II cuticular Hb2

Target products collectionGo to KRT82 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP8529-Ag-1/ GM-Tg-hg-IP8529-Ag-2 Human KRT82 protein Human
GM-Tg-rg-IP8529-Ag-1/ GM-Tg-rg-IP8529-Ag-2 Rat KRT82 protein Rat
GM-Tg-mg-IP8529-Ag-1/ GM-Tg-mg-IP8529-Ag-2 Mouse KRT82 protein Mouse
GM-Tg-cynog-IP8529-Ag-1/ GM-Tg-cynog-IP8529-Ag-2 Cynomolgus/Rhesus macaque KRT82 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP8529-Ag-1/ GM-Tg-felg-IP8529-Ag-2 Feline KRT82 protein Feline
GM-Tg-cang-IP8529-Ag-1/ GM-Tg-cang-IP8529-Ag-2 Canine KRT82 protein Canine
GM-Tg-bovg-IP8529-Ag-1/ GM-Tg-bovg-IP8529-Ag-2 Bovine KRT82 protein Bovine
GM-Tg-equg-IP8529-Ag-1/ GM-Tg-equg-IP8529-Ag-2 Equine KRT82 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP8529-Ag-1/ GM-Tg-hg-IP8529-Ag-2; GM-Tg-rg-IP8529-Ag-1/ GM-Tg-rg-IP8529-Ag-2;
GM-Tg-mg-IP8529-Ag-1/ GM-Tg-mg-IP8529-Ag-2; GM-Tg-cynog-IP8529-Ag-1/ GM-Tg-cynog-IP8529-Ag-2;
GM-Tg-felg-IP8529-Ag-1/ GM-Tg-felg-IP8529-Ag-2; GM-Tg-cang-IP8529-Ag-1/ GM-Tg-cang-IP8529-Ag-2;
GM-Tg-bovg-IP8529-Ag-1/ GM-Tg-bovg-IP8529-Ag-2; GM-Tg-equg-IP8529-Ag-1/ GM-Tg-equg-IP8529-Ag-2
Products Name KRT82 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name KRT82
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine KRT82 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.